Grants, awards and donations
The Anders Jahre prize 2026 awarded a KI brain researcher
Anders Jahre Senior Medical Prize 2026 is awarded to Professor Ole Kiehn, Karolinska Institutet and University of Copenhagen. Professor Kiehn receives the main Jahre prize for his groundbreaking discoveries on the organisation of and the function of neural circuits that control movements. These are findings of great significance for the treatment of disorders such as ALS and Parkinson’s disease.
Marcus Buggert awarded the Eric K. Fernström prize 2026
Docent Marcus Buggert at the Department of Medicine, Huddinge, Karolinska Institutet, is awarded the Eric K. Fernström prize for particularly promising and successful researchers, for his remarkable research on the function of T cells in the human immune system and their importance for new therapies.
Pär Nordlund awarded the Prize for Innovation and Utilisation 2026
Pär Nordlund is an internationally prominent researcher who successfully combines excellence in basic research with tangible societal impact. By translating groundbreaking discoveries into successful companies, he has contributed to accelerating the development of new medicines and strengthening the link between academia and industry. He is now awarded the 2026 Prize for Innovation and Utilisation.
Philanthropic support from the Savén Family bolsters colorectal cancer research
Donations by Björn Savén and his wife Inger Savén to Karolinska Institutet’s research on colorectal cancer will hopefully improve our understanding of the disease and the possibility of early detection. One of the aims of the research is to enhance the disease prognosis by increasing the number of people tested at an early stage.
The magazine Medicinsk Vetenskap on AI in healthcare
More and more people are turning to Dr AI for advice
Dr AI has become a colleague of Dr Google. Researchers see both benefits and risks in this development. First published in the magazine Medicinsk Vetenskap no 2 2026.
How AI can accelerate drug development
Andreas Luttens has trained an algorithm that can explore the so-called chemical space – all conceivable combinations of atoms and bonds. First published in the magazine Medicinsk Vetenskap no 2 2026.
The Conversation
New study downplays the risk of atrial fibrillation in fit people
New research suggests that the risk of atrial fibrillation in highly fit people is lower than previously thought. The benefits of high fitness levels, including lower rates of cardiovascular disease, clearly outweigh any potential downsides. Read the article in The Conversation.
Why has PCOS been given a new name?
After decades of research, PCOS is now being renamed PMOS. The new name reflects a growing understanding that the condition is a complex hormonal and metabolic disorder affecting far more than fertility.
The shot that could stop cancer before it begins
Vaccines like the HPV shot are already proving that cancer can be prevented before it develops, by stopping the infections that trigger it years or even decades later. Evidence from long-term studies shows that getting vaccinated early – before exposure – dramatically reduces cancer risk, highlighting the critical importance of early immunisation.
More articles by KI researchers published in The Conversation
From cold-resistant genes to face masks, Karolinska Institutet researchers contribute to the global public discourse on a range of topics through our collaboration with the international news site The Conversation.
Selected top publications
Staff practices determine the use of coercion against young people
Astrid Moell et al, Lancet Psychiatry, June 2026
From PCOS to PMOS: why the name of a disease matters
Elisabet Stener-Victorin et al, Nature Medicine, May 2026
Chronic bowel disease involves multiple types of inflammation happening at once
Eduardo J. Villablanca et al, Immunity, May 2026
New insights into protein breakdown in cells pave the way for new medicines
Helin Norberg et at, Trends in Pharmacological Sciences, April 2026
More patients receive recommended heart failure treatment
Gianluigi Savarese et al, European Heart Journal, April 2026
More high-impact publications